The CBN Credit support for the Healthcare sector is an on-lending intervention scheme for the Healthcare sector developed as part of the pro-active measures to cushion the economic impact of the coronavirus (COVID-19) pandemic. The initiative was developed to provide funding to indigenous pharmaceutical companies and other organizations in the healthcare value chain to enable them increase capacity to meet the increasing demand for healthcare arising from the coronavirus pandemic.
Eligible Participants include
- Healthcare product manufacturers
- Healthcare service providers/ medical facilities
- Pharmaceutical/medical products distribution and logics services
- Other human healthcare service providers
For working Capital: 20% of their average turnover for the last 3 years up to a maximum of N500 million per obligor. Where the business is not up to 3 years in operation, 20% of the previous year’s turnover would be considered
For Term Loan: Maximum loan amount of N2 billion
- Working capital shall be for a maximum period of one (1) year, with provision for rollover not more than three (3) years
- Term loan shall have a maximum tenor of not more than 10 years with a maximum of one year moratorium on repayment
For construction projects, the tenor shall be determined by the completion date.
- Applicants must operate a current or corporate account with a commercial bank for at least 3 months to qualify.
- Business must be registered as a Sole Proprietorship, Partnership or Limited Liability Company.
- Business must have an identifiable place of operation verified by an account Officer.
- Applicants must not have a history of returned cheques or questionable character.
- Applicants must not have non-performing facilities in any bank.
- Applicants must provide a 6 months statement of account from any Commercial Bank in Nigeria.
- Business must have been in operation for at least 1 year, with a steady cash flow.
- All necessary licenses to operate the business must be in place.
- DSR of obligor shall not exceed 33%, factoring in customer’s cumulative business net turnover in all banks, as well as global loan exposures.